FGF2-FGFR1 Pathway Activation Together With Thymidylate Synthase Upregulation Is Induced in Pemetrexed-Resistant Lung Cancer Cells

Oncotarget - United States
doi 10.18632/oncotarget.26622
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Rapamycin Downregulates Thymidylate Synthase and Potentiates the Activity of Pemetrexed in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2014English

Thymidylate Synthase Expression as a Predictive Biomarker of Pemetrexed Sensitivity in Advanced Non-Small Cell Lung Cancer

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2015English

Significance of Thymidylate Synthase Expression for Resistance to Pemetrexed in Pulmonary Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2013English

FGF2-induced Upregulation of DNA Polymerase-Δ P12 Subunit in Endothelial Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Dexamethasone Pretreatment Impairs the Thymidylate Synthase Inhibition Mediated Flare in Thymidine Salvage Pathway Activity in Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2018English

Cisplatin Resistance in Gastric Cancer Cells Is Associated With HER2 Upregulation-Induced Epithelial-Mesenchymal Transition

Scientific Reports
Multidisciplinary
2016English

Inhibition of dUTPase Induces Synthetic Lethality With Thymidylate Synthase-Targeted Therapies in Non-Small Cell Lung Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Thymidylate Synthase

Science-Business eXchange
2009English

Thymidylate Synthase in Situ Protein Expression and Survival in Stage I Nonsmall-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy